EC Number | Application | Comment | Organism |
---|---|---|---|
4.1.1.15 | medicine | injection of gamma-aminobutanoate agonists baclofen and muscimol increases luteinising hormone in serum after 6 h. Intraperitoneal treatment with gamma-aminobutanaote A agonist muscimol decreases mRNA of isoform GAD65 approximately 10fold, gamma-aminobutanaote transaminase approximately 15fold and tyrosine hydroxylase approximately 3fold in telencephalon. Intraperitoneal treatment with gamma-aminobutanaote B agonist baclofen reduces mRNA levels of isoform GAD67 approximately 2fold and gamma-aminobutanaote transaminase approximately 2fold in hypothalamus | Carassius auratus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.6.1.19 | Baclofen | injection of 0.01 mg/g body weight reduces GABA-T mRNA level 2fold; i.p. injection of sexually regressed female goldfish results in significant increase in serum luteinising hormone after 6 h. About 2fold decrease both in glutamic acid decarboxylase 67 and gamma-aminobutanoate transaminase mRNa in the hypothalamus | Carassius auratus | |
2.6.1.19 | Muscimol | injection of 0.001 mg/g body weight reduces GABA-T mRNA level 15fold; i.p. injection of sexually regressed female goldfish results in significant increase in serum luteinising hormone after 6 h. About 10fold decrease in glutamic acid decarboxylase 65 and 15fold in gamma-aminobutanoate transaminase mRNa in the hypothalamus | Carassius auratus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.6.1.19 | Carassius auratus | - |
- |
- |
4.1.1.15 | Carassius auratus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.6.1.19 | brain | - |
Carassius auratus | - |
2.6.1.19 | hypothalamus | - |
Carassius auratus | - |
2.6.1.19 | telencephalon | - |
Carassius auratus | - |
4.1.1.15 | brain | - |
Carassius auratus | - |
4.1.1.15 | hypothalamus | intraperitoneal treatment with gamma-aminobutanaote B agonist baclofen reduces mRNA levels of isoform GAD67 approximately 2fold and gamma-aminobutanaote transaminase approximately 2fold | Carassius auratus | - |
4.1.1.15 | telencephalon | intraperitoneal treatment with gamma-aminobutanaote A agonist muscimol decreases mRNA of isoform GAD65 approximately 10fold, gamma-aminobutanaote transaminase approximately 15fold and tyrosine hydroxylase approximately 3fold | Carassius auratus | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.6.1.19 | GABA-T | - |
Carassius auratus |
2.6.1.19 | GABA-transaminase | - |
Carassius auratus |